Searching for the role and the most suitable biomarkers of oxidative stress in Alzheimer's disease and in other neurodegenerative diseases

Neurobiology of Aging

Volumn 26, Issue 5, 2005, Pages 587-595

  Migliore, L ^a   Fontana, I ^a   Colognato, R ^a   Coppede, F ^a   Siciliano, G ^a   Murri, L ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Alzheimer; Neurodegenerative diseases; Oxidative stress; Peripheral biomarkers

Indexed keywords

PURINE; PYRIMIDINE;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; BLOOD CELL; BODY FLUID; COMET ASSAY; DEGENERATIVE DISEASE; DISEASE MARKER; DNA DAMAGE; FIBROBLAST; HIGH RISK PATIENT; HUMAN; LEUKOCYTE; MACROMOLECULE; NEUROIMAGING; OXIDATION; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT;

EID: 13644253800     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2004.10.002     Document Type: Note

References (105)

1. M.G. Andreassi, N. Botto, A. Rizza, M.G. Colombo, C. Palmieri, and S. Berti Deoxyribonucleic acid damage in human lymphocytes after percutaneous transluminal coronary angioplasty J Am Coll Cardiol 40 5 2002 862 868
2. S. Apostolski, Z. Marinkovic, A. Nikolic, D. Blagojevic, M.B. Spasic, and A.M. Michelson Glutathione peroxidase in amyotrophic lateral sclerosis: the effects of selenium supplementation J Environ Pathol Toxicol Oncol 17 3-4 1998 325 329
3. O.I. Aruoma Free radicals, oxidative stress, and antioxidants in human health and disease J Am Chem Soc 75 1998 199
4. Beal MF. Oxidative damage as an early marker of Alzheimer's disease and mild cognitive impairment. Neurobiol Aging, this issue.
5. F. Blandini, E. Martignoni, R. Ricotti, F. di Jeso, and G. Nappi Determination of hydroxyl free radical formation in human platelets using high-performance liquid chromatography with electrochemical detection J Chromatogr B Biomed Sci Appl 732 1 1999 213 220
6. J. Blasiak, M. Arabski, R. Krupa, K. Wozniak, M. Zadrozny, and J. Kasznicki DNA damage and repair in type 2 diabetes mellitus Mutat Res 554 1-2 2004 297 304
7. J. Blasiak, M. Arabski, R. Krupa, K. Wozniak, J. Rykala, and A. Kolacinska Basal, oxidative and alkylative DNA damage, DNA repair efficacy and mutagen sensitivity in breast cancer Mutat Res 554 1-2 2004 139 148
8. M. Bogdanov, R.H. Brown, W. Matson, R. Smart, D. Hayden, and H. O'Donnell Increased oxidative damage to DNA in ALS patients Free Radic Biol Med 29 7 2000 652 658
9. S. Bonassi, L. Hagmar, U. Stromberg, A.H. Montagud, H. Tinnerberg, and A. Forni Chromosomal aberrations in lymphocytes predict human cancer independently of exposure to carcinogens. European Study Group on Cytogenetic Biomarkers and Health Cancer Res 60 6 2000 1619 1625
10. D. Bonnefont-Rousselot, L. Lacomblez, M. Jaudon, S. Lepage, F. Salachas, and G. Bensimon Blood oxidative stress in amyotrophic lateral sclerosis J Neurol Sci 178 1 2000 57 62
11. N. Botto, S. Masetti, L. Petrozzi, C. Vassalle, S. Manfredi, and A. Biagini Elevated levels of oxidative DNA damage in patients with coronary artery disease Coron Artery Dis 13 5 2002 269 274
12. C. Buhmann, S. Arlt, A. Kontush, T. Moller-Bertram, S. Sperber, and M. Oechsner Plasma and CSF markers of oxidative stress are increased in Parkinson's disease and influenced by antiparkinsonian medication Neurobiol Dis 15 1 2004 160 170
13. D.A. Butterfield, and E.R. Stadtman Protein oxidation processes in aging brain Adv Cell Aging Gerontol 2 1997 161 191
14. D.A. Butterfield Proteomics: a new approach to investigate oxidative stress in Alzheimer's disease brain Brain Res 1000 2004 1 7
15. D.A. Butterfield, and A.I. Bush Alzheimer's amyloid beta-peptide (1-42): involvement of methionine residue 35 in the oxidative stress and neurotoxicity properties of this peptide Neurobiol Aging 25 5 2004 563 568
16. A.C. Carr, B.Z. Zhu, and B. Frei Potential antiatherogenic mechanisms of ascorbate (Vitamin C) and α-tocopherol (Vitamin E) Circ Res 87 2000 349
17. M.T. Carrì, A. Ferri, M. Cozzolino, L. Calabrese, and G. Rotilio Neurodegeneration in amyotrophic lateral sclerosis: the role of oxidative stress and altered homeostasis of metals Brain Res Bull 61 4 2003 365 374
18. C. Cecchi, C. Fiorillo, S. Sorbi, S. Latorraca, B. Nacmias, and S. Bagnoli Oxidative stress and reduced antioxidant defenses in peripheral cells from familial Alzheimer's patients Free Radic Biol Med 33 10 2002 1372 1379
19. J. Choi, C.A. Malakowsky, J.M. Talent, C.C. Conrad, and R.W. Gracy Identification of oxidized plasma proteins in Alzheimer's disease Biochem Biophys Res Commun 293 5 2002 1566 1570
20. A. Collins Oxidative DNA damage, antioxidants, and cancer BioEssays 21 1999 238 246
21. C.C. Conrad, P.L. Marshall, J.M. Talent, C.A. Malakowsky, J. Choi, and R.W. Gracy Oxidized proteins in Alzheimer's plasma Biochem Biophys Res Commun 275 2 2000 678 681
22. T.M. Dawson, and V.L. Dawson Molecular pathways of neurodegeneration in Parkinson's disease Science 302 5646 2003 819 822
23. E.A. Decker The role of phenolics, conjugated linoleic acid, carnosine and pyrrolquinolinequinone as nonessential dietary antioxidants Nutr Rev 53 1995 49
24. S.J. Duthie, A. Ma, M.A. Ross, and A.R. Collins Antioxidant supplementation decreases oxidative DNA damage in human lymphocytes Cancer Res 56 6 1996 1291 1295
25. Y.Z. Fang Free radicals and nutrition Y.Z. Fang RL. Zheng Theory and application of free radical biology 2002 Scientific Press Beijing 647
26. F. Faust, F. Kassie, S. Knasmuller, R.H. Boedecker, M. Mann, and V. Mersch-Sundermann The use of the alkaline comet assay with lymphocytes in human biomonitoring studies Mutat Res 566 3 2004 209 229
27. I. Fontana, I. Marseglia, S. Molinu, R. Colognato, S. Bargagna, and G. Cioni Oxidative DNA damage in peripheral cells of Down Syndrome patients FISV 30 September-3 October 2004
28. B. Friguet, and L.I. Szweda Inhibition of the multicatalytic proteinase (proteasome) by 4-hydroxy-2-nonenal cross-linked protein FEBS Lett 405 1 1997 21 25
29. H.A. Ghanbari, K. Ghanbari, P.L. Harris, P.K. Jones, Z. Kubat, and R.J. Castellani Oxidative damage in cultured human olfactory neurons from Alzheimer's disease patients Aging Cell 3 1 2004 41 44
30. G.E. Gibson, H. Zhang, K.R. Sheu, and L.C. Park Differential alterations in antioxidant capacity in cells from Alzheimer patients Biochim Biophys Acta 1502 2000 319 329
31. G.E. Gibson, and H. Zhang Effects of Ginkgo biloba (EGb761) on metabolism of reactive oxygen species in fibroblasts from Alzheimer's disease patients and controls Y. Christen Salal Advances in Ginkgo Biloba extract research ginkgo biloba Extract (EGB 761) as a neuroprotective agent from basic studies to clinical trials, vol. 8 2000 Marseille IPSEN Foundation pp. 108-121
32. G.E. Gibson, H. Zhang, H. Xu, L.C. Park, and T.M. Jeitner Oxidative stress increases internal calcium stores and reduces a key mitochondrial enzyme Biochim Biophys Acta 1586 2 2002 177 189
33. Gibson EG, Haung HM. Oxidative stress in Alzheimer's disease. Neurobiol Aging, this issue.
34. L. Giovannelli, V. Pitozzi, S. Riolo, and P. Dolara Measurement of DNA breaks and oxidative damage in polymorphonuclear and mononuclear white blood cells: a novel approach using the comet assay Mutat Res 538 1-2 2003 71 80
35. P.F. Good, A. Hsu, P. Werner, D.P. Perl, and C.W. Olanow Protein nitration in Parkinson's disease J Neuropathol Exp Neurol 57 4 1998 338 342
36. C.K. Hand, and G.A. Rouleau Familial amyotrophic lateral sclerosis Muscle Nerve 25 2 2002 135 159
37. T.M. Haqqi, D.D. Anthony, S. Gupta, N. Ahmad, M.S. Lee, and G.K. Kumar Prevention of collagen-induced arthritis in mice by a polyphenolic fraction from green tea Proc Natl Acad Sci USA 96 1999 4524 4529
38. M. Harangi, E.E. Remenyik, I. Seres, Z. Varga, E. Katona, and G. Paragh Determination of DNA damage induced by oxidative stress in hyperlipidemic patients Mutat Res 513 1-2 2002 17 25
39. N. Hattori, and Y. Mizuno Pathogenetic mechanisms of parkin in Parkinson's disease Lancet 364 9435 2004 722 724
40. Y. Ihara, A. Mori, T. Hayabara, M. Kawai, R. Namba, and K. Nobukuni Superoxide dismutase and free radicals in sporadic amyotrophic lateral sclerosis: relationship to clinical data J Neurol Sci 134 1-2 1995 51 56
41. T.V. Ilic, M. Jovanovic, A. Jovicic, and M. Tomovic Oxidative stress indicators are elevated in de novo Parkinson's disease patients Funct Neurol 14 3 1999 141 147
42. S.V. Jovanovic, Clements, and K. MacLeod Biomarkers of oxidative stress are significantly elevated in Down syndrome Free Radic Biol Med 25 1998 1044 1048
43. E. Kadioglu, S. Sardas, S. Aslan, E. Isik, and A. Esat Karakaya Detection of oxidative DNA damage in lymphocytes of patients with Alzheimer's disease Biomarkers 9 2 2004 203 209
44. J. Kalra, A.H. Rajput, S.V. Mantha, A.K. Chaudhary, and K. Prasad Oxygen free radical producing activity of polymorphonuclear leukocytes in patients with Parkinson's disease Mol Cell Biochem 112 2 1992 181 186
45. E. Kan, U. Undeger, M. Bali, and N. Basaran Assessment of DNA strand breakage by the alkaline comet assay in dialysis patients and the role of Vitamin E supplementation Mutat Res 520 1-2 2002 151 159
46. J.N. Keller, J. Gee, and Q. Ding The proteasome in brain aging Ageing Res Rev 1 2002 279 293
47. A. Kikuchi, A. Takeda, H. Onodera, T. Kimpara, K. Hisanaga, and N. Sato Systemic increase of oxidative nucleic acid damage in Parkinson's disease and multiple system atrophy Neurobiol Dis 9 2 2002 244 248
48. W.E. Klunk Blood and CSF biomarkers for AD revisited: what's new, what's good, and is this where we should be looking? Neurobiol Aging 23 4 2002 517 519 discussion 521-52
49. D.K. Lahiri, and N.H. Greig Lethal weapon: amyloid beta-peptide, role in the oxidative stress and neurodegeneration of Alzheimer's disease Neurobiol Aging 25 5 2004 581 587
50. F. Li, N.Y. Calingasan, F. Yu, W.M. Mauck, M. Toidze, and C.G. Almeida Increased plaque burden in brains of APP mutant MnSOD heterozygous knockout mice J Neurochem 89 5 2004 1308 1312
51. M.A. Lovell, W.D. Ehmann, and M.P. Mattson Markesbery WR. Elevated 4-hydroxynonenal in ventricular fluid in Alzheimer's disease Neurobiol Aging 18 5 1997 457 461
52. J. Luders, J. Demand, and J. Hohfeld The ubiquitin-related BAG-1 provides a link between the molecular chaperones Hsc70/Hsp70 and the proteasome J Biol Chem 275 7 2000 4613 4617
53. W.R. Markesbery Oxidative stress hypothesis in Alzheimer's disease Free Radic Biol Med 23 1 1997 134 147
54. L.T. McGrath, B.M. McGleenon, S. Brennan, D. McColl, S. McILroy, and A.P. Passmore Increased oxidative stress in Alzheimer's disease as assessed with 4-hydroxynonenal but not malondialdehyde QJM 94 9 2001 485 490
55. P. Mecocci, C. Polidori, A. Cherubini, F. Chionne, R. Cecchetti, and U. Senin Oxidative damage to DNA lympocytes from AD patients Neurology 51 1998 1014 1017
56. P. Mecocci, M.C. Polidori, A. Cherubini, T. Ingegni, P. Mattioli, and M. Catani Lymphocyte oxidative DNA damage and plasma antioxidants in Alzheimer disease Arch Neurol 59 5 2002 794 798
57. L. Migliore, and F. Coppedè Genetic and environmental factors in cancer and neurodegenerative diseases Mutat Res 512 2-3 2002 135 153
58. L. Migliore, L. Petrozzi, C. Lucetti, G. Gambaccini, S. Bernardini, and R. Scarpato Oxidative damage and cytogenetic analysis in leukocytes of Parkinson's disease patients Neurology 58 2002 1809 1815
59. L. Migliore, S. Molinu, A. Naccarati, M. Mancuso, A. Rocchi, and G. Siciliano Evaluation of cytogenetic and DNA damage in mitochondrial disease patients: effects of coenzyme Q10 therapy Mutagenesis 19 1 2004 43 49
60. Migliore L, Fontana I, Trippi F, Colognato R, Coppedè F, Tognoni G, et al. Oxidative DNA damage in peripheral leukocytes of mild congitive impairment and AD patients. Neuorbiol Aging, this issue.
61. Migliore L, Boni G, Bernardini R, Trippi F, Colognato R, Fontana I, et al. Susceptibility to chromosome malsegregation in lymphocytes of women who had a Down syndrome child in young age. Neurobiol Aging, submitted for publication.
62. T.J. Montine, M.F. Beal, M.E. Cudkowicz, H. O'Donnell, R.A. Margolin, and L. McFarland Increased CSF F2-isoprostane concentration in probable AD Neurology 52 3 1999 562 565
63. M.J. Morillas, E. Guillamet, J. Surralles, A. Creus, and R. Marcos Spontaneous and induced genetic damage in T lymphocyte subsets evaluated by the Comet assay Mutat Res 514 1-2 2002 39 48
64. M. Mòrocz, J. Kalman, A. Juhàsz, I. Sinkò, A.P. McGlynn, and C.S. Downes Elevated levels of oxidative DNA damage in lymphocytes from patients with Alzheimer's disease Neurobiol Aging 23 2002 47 53
65. D.P. Muller Antioxidant therapy in neurological disorders Adv Exp Med Biol 264 1990 475
66. F. Nanjo, K. Goto, R. Seto, M. Suzuki, M. Sakai, and Y. Hara Scavenging effects of tea catechins and their derivatives on 1,1-diphenyl-2-picrylhydrazyl radical Free Radic Biol Med 21 1996 895 902
67. P. Odetti, G. Angelini, D. Dapino, D. Zaccheo, S. Garibaldi, and F. Dagna-Bricarelli Early glycoxidation damage in brains from Down's syndrome Biochem Biophys Res Commun 243 3 1998 849 851
68. P.I. Oteiza, O.D. Uchitel, F. Carrasquedo, A.L. Dubrovski, J.C. Roma, and C.G. Fraga Evaluation of antioxidants, protein, and lipid oxidation products in blood from sporadic amyotrophic lateral sclerosis patients Neurochem Res 22 4 1997 535 539
69. R.K. Pearce, A. Owen, S. Daniel, P. Jenner, and C.D. Marsden Alterations in the distribution of glutathione in the substantia nigra in Parkinson's disease J Neural Transm 104 6-7 1997 661 677
70. T.L. Perry, D.V. Godin, and S. Hansen Parkinson's disease: a disorder due to nigral glutathione deficiency? Neurosci Lett 33 3 1982 305 310
71. G. Perry, A. Nunomura, K. Hirai, X. Zhu, M. Perez, and J. Avila Is oxidative damage the fundamental pathogenic mechanism of Alzheimer's and other neurodegenerative diseases? Free Radic Biol Med 33 11 2002 1475 1479
72. R.C. Petersen Mild cognitive impairment: transition between aging and Alzheimer's disease Neurologia 15 2000 93 101
73. A. Petronis Alzheimer's disease and Down syndrome: from meiosis to dementia Exp Neurol 158 1999 403 413
74. D. Praticò, C. Clark, V.M. Lee, J.Q. Trojanowski, J. Rokach, and G.A. Fitzgerald Increased 8,12-iso-iPF(2 alpha)-IV in Alzheimer's disease: correlation of specific noninvasive index of lipid peroxidation with disease severity Ann Neurol 48 2000 809 812
75. Praticò D. Peripheral biomarkers of oxidative damage in Alzheimer's disease: the road ahead. Neurobiol Aging, this issue.
76. C. Rice-Evans Flavonoid antioxidants Curr Med Chem 8 2001 797 807
77. N. Salah, N.J. Miller, G. Paganga, L. Tijburg, G.P. Bolwell, and C. Rice-Evans Polyphenolic flavanols as scavengers of aqueous phase radicals and as chain-breaking antioxidants Arch Biochem Biophys 322 1995 339 346
78. S. Sardas, M. Yilmaz, U. Oztok, N. Cakir, and A.E. Karakaya Assessment of DNA strand breakage by comet assay in diabetic patients and the role of antioxidant supplementation Mutat Res 490 2 2001 123 129
79. H. Schroeter, J.P. Spencer, C. Rice-Evans, and R.J. Williams Flavonoids protect neurons from oxidized low-density-lipoprotein-induced apoptosis involving c-Jun N-terminal kinase (JNK), c-Jun and caspase-3 Biochem J 358 2001 547 557
80. N. Schupf, D. Kapell, B. Nightingale, J.H. Lee, J. Mohlenhoff, and S. Bewley Specificity of the fivefold increase in AD in mothers of adults with Down syndrome Neurology 57 6 2001 979 984
81. M.L. Selley, D.R. Close, and S.E. Stern The effect of increased concentrations of homocysteine on the concentration of (E)-4-hydroxy-2-nonenal in the plasma and cerebrospinal fluid of patients with Alzheimer's disease Neurobiol Aging 23 3 2002 383 388
82. J.A. Serra, R.O. Dominguez, E.S. de Lustig, E.M. Guareschi, A.L. Famulari, and E.L. Bartolome Parkinson's disease is associated with oxidative stress: comparison of peripheral antioxidant profiles in living Parkinson's, Alzheimer's and vascular dementia patients J Neural Transm 108 10 2001 1135 1148
83. T.B. Sherer, R. Betarbet, and J.T. Greenamyre Environment, mitochondria, and Parkinson's disease Neuroscientist 8 3 2002 192 197
84. J. Sierens, J.A. Hartley, M.J. Campbell, A.J. Leathem, and J.V. Woodside Effect of phytoestrogen and antioxidant supplementation on oxidative DNA damage assessed using the comet assay Mutat Res 485 2 2001 169 176
85. E.P. Simpson, Y.K. Henry, J.S. Henkel, R.G. Smith, and S.H. Appel Increased lipid peroxidation in sera of ALS patients: a potential biomarker of disease burden Neurology 62 10 2004 1758 1765
86. W. Slikker, M.B. Youdim, G.C. Palmer, E. Hall, C. Williams, and B. Trembly The future of neuroprotection Ann N Y Acad Sci 890 1999 529 533
87. Smith MA, Nunomura A, Lee H, Zhu X, Moreira PI, Avila J, et al. Chronological primacy of oxidative stress in Alzheimer disease. Neurobiol Aging, this issue.
88. R.G. Smith, Y.K. Henry, M.P. Mattson, and S.H. Appel Presence of 4-hydroxynonenal in cerebrospinal fluid of patients with sporadic amyotrophic lateral sclerosis Ann Neurol 44 4 1998 696 699
89. S. Song, S.Y. Kim, Y.M. Hong, D.G. Jo, J.Y. Lee, and S.M. Shim Essential role of E2-25K/Hip-2 in mediating amyloid-beta neurotoxicity Mol Cell 12 3 2003 553 563
90. JPE Spencer, H. Schroeter, G. Kuhnle, S.K. Srai, R.M. Tyrrell, and U. Hahn Epicatechin and its in vivo metabolite, 3V-O-methyl epicatechin, protect human fibroblasts from oxidative-stress-induced cell death involving caspase-3 activation Biochem J 354 2001 493 500
91. C.E. Teunissen, J. de Vente, H.W. Steinbusch, and C. De Bruijn Biochemical markers related to Alzheimer's dementia in serum and cerebrospinal fluid Neurobiol Aging 23 4 2002 485 508
92. A. Theriault, J.T. Chao, Q. Wang, A. Gapor, and K. Adeli Tocotrienol. A review of its therapeutic potential Clin Biochem 32 1999 309
93. H. Tohgi, T. Abe, K. Yamazaki, T. Murata, E. Ishizaki, and C. Isobe Remarkable increase in cerebrospinal fluid 3-nitrotyrosine in patients with sporadic amyotrophic lateral sclerosis Ann Neurol 46 1 1999 129 131
94. F. Trippi, N. Botto, R. Scarpato, L. Petrozzi, U. Bonuccelli, and S. Latorraca Spontaneous and induced chromosome damage in somatic cells of sporadic and familial Alzheimer's disease patients Mutagenesis 16 2001 323 327
95. E.E. Tuppo, L.J. Forman, B.W. Spur, R.E. Cheng-Ting, A. Chopra, and A. Cavalieri Sign of lipid peroxidation as mesured in the urine of patients with probable Alzheimer's disease Brain Res Bull 54 2001 565 568
96. F.W. van Leeuwen Neuropeptide research discloses part of the secrets of Alzheimer's disease neuropathogenesis: state of the art Neurosci Lett 361 1-3 2004 124 127
97. 2-isoprostane levels are inareased in Alzheimer's disease: evidence of increased oxidative stress in vivo Alzheimers' Rep 2 1999 227 282
98. D.M. Walsh, I. Klyubin, J.V. Fadeeva, W.K. Cullen, R. Anwyl, and M.S. Wolfe Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo Nature 416 6880 2002 535 539
99. Z.Y. Wang, M.T. Huang, Y.R. Lou, J.G. Xie, K.R. Reuhl, and H.L. Newmark Inhibitory effects of black tea, green tea, decaffeinated black tea, and decaffeinated green tea on ultraviolet B light-induced skin carcinogenesis in 7,12-dimethylbenz[a]anthracene-initiated SKH-1 mice Cancer Res 54 1994 3428 3455
100. C.S. Yang, and Z.Y. Wang Tea and cancer J Natl Cancer Inst 85 1993 1038 1049
101. S.M. Yatin, S. Varadarajan, C.D. Link, and D.A. Butterfield In vitro and in vivo oxidative stress associated with Alzheimer's amyloid beta-peptide (1-42) Neurobiol Aging 20 3 1999 325 330
102. T. Yokota, K. Igarashi, T. Uchihara, K. Jishage, H. Tomita, and A. Inaba Delayed-onset ataxia in mice lacking alpha -tocopherol transfer protein: model for neuronal degeneration caused by chronic oxidative stress Proc Natl Acad Sci USA 98 26 2001 15185 15190
103. K. Zarkovic 4-hydroxynonenal and neurodegenerative diseases Mol Aspects Med 24 4-5 2003 293 303
104. J. Zhang, and D.R. Goodlett Proteomic approach to studying Parkinson's disease Mol Neurobiol 29 3 2004 271 288
105. X. Zhu, A.K. Raina, H.G. Lee, M. Chao, A. Nunomura, and M. Tabaton Oxidative stress and neuronal adaptation in Alzheimer disease: the role of SAPK pathways Antioxid Redox Signal 5 5 2003 571 576